24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Diabetes
Resources
Basic InformationLatest News
AHA News: Diabetes and Dementia Risk: Another Good Reason to Keep Blood Sugar in CheckAmericans With Diabetes Were Hit Hard by COVID PandemicAHA News: The Challenge of Diabetes in the Black Community Needs Comprehensive SolutionsWhich Blood Sugar Meds Work Best Against Type 2 Diabetes?Walmart to Offer Low-Priced InsulinPoorly Managed Diabetes Raises Odds for More Severe COVIDWeekly Injected Drug Could Boost Outcomes for Patients With Type 2 DiabetesLockdown Weight Gain May Have Caused Surge in New Diabetes Cases in KidsAmerica Is Losing the War Against DiabetesA Fruitful Approach to Preventing DiabetesIn People With Type 1 Diabetes, Poor Blood Sugar Control Could Raise Dementia RiskBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the WayWhen Diabetes Strikes in Pregnancy, Do Women Eat Healthier?Being a 'Night Owl' Raises Odds for Diabetes If You're Obese'Prediabetes' Raises Odds for Heart Attack, StrokeDementia Risk Rises as Years Lived With Type 2 Diabetes IncreasesCOVID-19 and Advanced Diabetes Can Be a Deadly Mix: StudyPandemic May Be Upping Cases of Severe Complication in Kids With DiabetesDiabetes Can Lead to Amputations, But Stem Cell Treatment Offers HopeCan a Drug Help Prevent Diabetic Vision Loss?Diabetes Is Deadlier for Black Americans: StudyLockdowns Gave Boost to Type 1 Diabetes Control in KidsComing Soon: Once-a-Week Insulin Injections?Common Type 2 Diabetes Meds Won't Raise Breast Cancer Risk: StudySome Kids With Type 1 Diabetes Face High Risk of Severe COVID-19Breakfast Timing Could Affect Your Odds for DiabetesBegin Routine Diabetes Screening at 35 for Overweight, Obese Americans: Task ForceCould a Drug Prevent Type 1 Diabetes in Those at Risk?Women With Type 1 Diabetes May Have Fewer Childbearing Years: StudyMeeting the Challenges of Type 1 Diabetes in the Teen YearsA Fifth of COVID Patients With Diabetes Die Within 1 Month of Hospitalization'Prediabetes' May Be Harming Your Brain, Study FindsDoes 'Prediabetes' Lead to Full-Blown Diabetes? Age May Be KeyObesity Helps Drive Half of New Diabetes Cases Among AmericansPatients With Diabetes Need More Counseling on Low Blood SugarInsulin May Not Need Refrigeration, Freeing Up Its Use in Poorer NationsAHA News: Reversing Prediabetes Linked to Fewer Heart Attacks, StrokesDiabetes Boosts Odds for Heart Trouble 10-fold in Younger WomenTips for Parents of Kids With DiabetesStrict Low-Carb Diets Could Push Type 2 Diabetes Into Remission, But Effect FadesCommon Diabetes Meds Tied to Serious COVID-19 ComplicationBlack Patients at Higher Risk When Type 1 Diabetes and COVID CombineWeight-Loss Surgery Lowers Long-Term Heart Risks for Diabetic TeensSurgery, Drugs Similar for Treating Severe Diabetic Eye DiseaseTreatment Reverses Young Man's Type 1 Diabetes. Will It Last?Type 2 Diabetes in Youth Is Especially Unhealthy: StudyDogs and Their Humans Share Same Diabetes Risk: StudyHigh Blood Sugar Ups COVID Risks, Even in Non-DiabeticsWeight-Loss Surgery Often Rids Patients of Type 2 Diabetes'Repeat After Me' for Better Diabetes Care
Links
Related Topics

Medical Disorders

COVID-19 and Advanced Diabetes Can Be a Deadly Mix: Study

HealthDay News
by By Ernie Mundell HealthDay Reporter
Updated: Apr 29th 2021

new article illustration

THURSDAY, April 29, 2021 (HealthDay News) -- COVID-19 is never a good diagnosis, but health risks are especially high in people with poorly controlled, advanced diabetes, a new study confirms.

The new report looked at pooled data from 22 studies that included a total of nearly 18,000 people.

Simply having diabetes didn't raise a COVID-19 patient's risk for death: The study found that COVID-19 death rates among people with diabetes were similar to those among people without diabetes.

It was the severity of diabetes -- along with other factors -- that seemed to up the odds for a poor outcome in patients who battled both diabetes and COVID-19, according to German researchers led by Sabrina Schlesinger of the Leibniz Center for Diabetes Research at Heinrich Heine University in Düsseldorf.

Being male, older and having other chronic health conditions, as well as being treated with insulin rather than the diabetes drug metformin, were risk factors for worse outcomes, the team reported April 28 in the journal Diabetologia.

Use of insulin as treatment indicates "a more progressive course of diabetes," Schlesinger's group pointed out.

Patients taking insulin to control their diabetes were 75% more likely to die from COVID-19 than non-insulin users. On the other hand, people treating their diabetes with metformin -- the first-line therapy used in most cases of type 2 diabetes -- were 50% less likely to die from COVID-19 than those not using metformin, the study found.

Men with diabetes were 28% more likely to die with COVID-19 than women with diabetes, and people 65 and older with diabetes were more than three times more likely to die than younger people with diabetes, the study found

Among people with diabetes, each 5-year increase in age was associated with a 43% increase in the relative risk of death from COVID-19, they noted.

Poorly controlled blood sugar levels, tested upon admission to hospital, were among the greatest factors upping death risk in people with diabetes and COVID-19, according to the study.

Two diabetes experts in the United States weren't surprised by the findings.

"The take-away is that people with diabetes should focus on what has always been the priority: A healthy lifestyle to control inflammation from chronically elevated glucose [blood sugar], which would lessen the risk of chronic diseases and organ damage," said Dr. Minisha Sood, an endocrinologist at Lenox Hill Hospital in New York City.

She added that "metformin appears to have a protective role, which is not surprising."

Dr. Barbara Keber is chair of family medicine a Glen Cove Hospital in Glen Cove, N.Y. Reading over the findings, she believes that the length of time a patient has lived with diabetes may be even more important to COVID-19 outcomes than its current severity. And she believes that more study is needed to get at the root of the key risk factors for these patients.

In the meantime, "all these types of patients have increased risk for death," Keber warned. "These groups of patients should therefore receive earlier interventions, such as the use of monoclonal antibodies [combination casrivimab and imdevimab shown to be the current best combination] as soon as they are diagnosed to prevent severe disease or death."

More information

The American Diabetes Association has more on COVID-19 and diabetes.


SOURCES: Minisha Sood, MD, endocrinologist, Lenox Hill Hospital, New York City, Barbara Keber, MD, chair, family medicine, Glen Cove Hospital, Glen Cove, N.Y.; Diabetologia, news release, April 28, 2021